ROVI Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Laboratorios Farmaceuticos ROVI SA

Watchlist Manager

Watchlist

Price: 58.7 EUR

Market Cap: €3B

	Laboratorios Farmaceuticos ROVI SA MAD:ROVI	ES
	Renforth Resources Inc F:9RR	CA
T	Toyobo Co Ltd F:TO7	JP
G	Glen Eagle Resources Inc XTSX:GER	CA
	Envipco Holding NV OTC:ENVHF	NL
	Citizen Watch Co Ltd F:CTZ	JP

Profitability Summary

Laboratorios Farmaceuticos ROVI SA's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

66%

Strong 3Y Average Gross Margin

63%

Gross Margin is Increasing

63% > 66%

Healthy Operating Margin

23%

Sustainable 3Y Average Operating Margin

25%

Declining Operating Margin

30% > 23%

Healthy Net Margin

24%

Sustainable 3Y Average Net Margin

19%

Net Margin is Increasing

23% > 24%

Exceptional Free Cash Flow Margin

22%

Strong 3Y Average Free Cash Flow Margin

11%

Free Cash Flow Margin is Increasing

5% > 22%

Exceptional ROE

29%

Exceptional 3Y Average ROE

Positive 3Y Average ROIC

23%

Declining ROIC

47% > 16%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.